India to cap prices of 137 cancer drugs from next month
The government will impose a price cap on 137 cancer drugs to help patients avoid financial ruin, following a supreme court ruling that described mark-ups as extortion.

The Indian government will impose a price cap on 137 cancer drugs starting next month. This measure is expected to reduce medicine prices by up to 70% and help cancer patients save 2,500 crore rupees annually. The move follows findings by the supreme court, where judges looked at mark-ups on cancer drugs and called the situation “carnage” and “extortion”.
Sarojam Radhakrishnan, a former bank employee in Kerala, filed a petition to the Kerala high court in 2022 after being diagnosed with breast cancer in 2021. Doctors prescribed life-saving targeted treatments, but the monthly cost of more than 63,000 rupees was far beyond her family’s means.
Analysis by the National Pharmaceutical Pricing Authority revealed a trade mark-up on some cancer drugs averaging 170%, with some extreme examples stretching to more than 700%. A 30% trade margin cap on the price of 42 drugs has been in place for some years, but the government has now imposed the cap on 137 other drugs.
High costs often lead patients to forgo treatment, sell land, or fall into debt. Many families walk out of the doctor’s consulting room upon hearing the estimated cost of treatment, which ranges from 38,000 to 380,000 rupees. Studies by the Public Health Foundation of India show that spending on healthcare pushes about 55 million Indians a year below the poverty line.
Dr Ravi Kannan, a surgical oncologist and director of Cachar cancer hospital and research centre in Silchar, Assam, said some families start the treatment, hoping against hope to manage the cost, but they cannot sustain the cost. Jyotsna Singh, co-convener of the Working Group on Access to Medicines and Treatments, said a “total overhaul” of the healthcare system was needed.
Singh suggested that companies and hospitals may try to find legal loopholes to wriggle out of the 30% cap by raising charges on other items. Supreme court judges have also asked the government’s lawyers why the cap should apply only to cancer drugs and not the entire range of non-patented drugs.
Key facts
- Prices of 137 cancer drugs in India are expected to fall by up to 70% from next month.
- The government has imposed a 30% trade margin cap on 137 cancer drugs.
- The measure is expected to help cancer patients save 2,500 crore rupees annually.
Three perspectives
Neutral
The Indian government is imposing a price cap on 137 cancer drugs starting next month following a supreme court investigation into high mark-ups.
Positive
The measure is expected to reduce medicine prices by up to 70% and help cancer patients save 2,500 crore rupees annually.
Negative
High medicine costs can lead patients to forgo treatment, sell land, or fall into debt, pushing about 55 million Indians below the poverty line each year.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.